🇺🇸 FDA
Patent

US 10493103

Peroxide formulations and methods and applicators for using the same

granted A61KA61K2800/872A61K33/40

Quick answer

US patent 10493103 (Peroxide formulations and methods and applicators for using the same) held by Aclaris Therapeutics, Inc. expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aclaris Therapeutics, Inc.
Grant date
Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K2800/872, A61K33/40, A61K47/10, A61K8/22